2. ntiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome https://t.co/73oHBNcRJf Tweets: 54
RT @Links_Medicus: Systematic review: Antithrombotic drugs for people with antiphospholipid syndrome – via @CochraneLibrary https://t.co/V…
Systematic review: Antithrombotic drugs for people with antiphospholipid syndrome – via @CochraneLibrary https://t.co/V7LJLvb7jw Summary: https://t.co/T3Apyd6d5g
🔗Systematic review: Antithrombotic drugs for people with antiphospholipid syndrome https://t.co/dPIwCb3cxa
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @CochraneUK: Anticoagulant drugs or antiplatelet drugs, or both, for reducing the risk of #bloodclots and #stroke in people with #antiph…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
RT @bhwords: New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in…
New Cochrane review of antiplatelet & anticoagulant agents for secondary prevention of stroke & other thromboembolic events in those with antiphospholipid syndrome comes to no firm conclusions due to limited data. We need more research... https://t
【コクランレビュー】抗リン脂質症候群患者における脳卒中および他の血栓塞栓イベントの2次予防のための抗血小板薬および抗凝固薬(NOACは標準用量のビタミンK拮抗薬と比較して血栓塞栓イベントおよび大出血において差がなかったが脳卒中リスクを増加させた。) #ペ読 https://t.co/yfFiYAiyB7
RT @CochraneLibrary: Anticoagulant drugs or antiplatelet drugs, or both, for reducing the risk of #bloodclots and #stroke in people with #a…
RT @CochraneUK: Anticoagulant drugs or antiplatelet drugs, or both, for reducing the risk of #bloodclots and #stroke in people with #antiph…
RT @CochraneUK: Anticoagulant drugs or antiplatelet drugs, or both, for reducing the risk of #bloodclots and #stroke in people with #antiph…
RT @CochraneUK: Anticoagulant drugs or antiplatelet drugs, or both, for reducing the risk of #bloodclots and #stroke in people with #antiph…
RT @CochraneUK: Anticoagulant drugs or antiplatelet drugs, or both, for reducing the risk of #bloodclots and #stroke in people with #antiph…
RT @CochraneLibrary: Anticoagulant drugs or antiplatelet drugs, or both, for reducing the risk of #bloodclots and #stroke in people with #a…
RT @CochraneLibrary: Anticoagulant drugs or antiplatelet drugs, or both, for reducing the risk of #bloodclots and #stroke in people with #a…
Anticoagulant drugs or antiplatelet drugs, or both, for reducing the risk of #bloodclots and #stroke in people with #antiphospholipid syndrome https://t.co/QaTX8Jq3UI Updated @CochraneStroke systematic review.